retatrutide glp1 Some Providers Prescribe Unapproved for Weight Loss at Alarming Rate Retatrutide: GLP-1, GLP-2 & GLP-3

Browning F

Faster degradation of GLP-1 means the body might not release enough insulin, especially for people who have type 2 diabetes [9]

Emerging Functions of the EGFR in Cancer

To view or add a comment, sign in A lot of GOOD news today in biotech + pharma: Breast cancer win in Ph3 trial for AstraZeneca + Daiichi Sankyo US (survival benefit vs chemotherapy) TCGX (TCG Crossover) raises $1.3B third fund focused on biotech + life sciences Trogenix's "Trojan Horse"-tech for cancer biotech lands 70M Series A AstraZeneca + Algen Biotechnologies sign up to $555M AI-powered drug discovery partnership Chiesi Group + Arbor Biotechnologies up to $2.1B rare disease partnership Eli Lilly and Company to invest up to $1B in Indian-based CDMO partnerships For all the news, check out the full (free) TLDR Biotech newsletter here ---------------------------------------- One skimmable email per day to keep up with biotech and pharma Big thanks to Promoveo Health for supporting this newsletter - they've built 100+ pharma sales teams for companies of all sizes, and they can do it for your org as well